(Q48970192)

17 February 2018

title

High-affinity [3H]6-nitroquipazine binding sites in rat brain (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

31 October 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

31 October 2022

1

K. Hashimoto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694774

31 October 2022

author name string

T. Goromaru

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694774

31 October 2022

language of work or name

English

0 references

publication date

1 May 1990

1 reference

17 February 2018

16 May 1990

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1694774

full work available at URL

31 October 2022

https://api.elsevier.com/content/article/PII:0014299990903103?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

https://api.elsevier.com/content/article/PII:0014299990903103?httpAccept=text/plain

31 October 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

European Journal of Pharmacology

31 October 2022

published in

1 reference

17 February 2018

volume

180

1 reference

17 February 2018

issue

2-3

1 reference

17 February 2018

page(s)

273-281

1 reference

17 February 2018

5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. I. Characteristics.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Quantitative autoradiography of [3H]indalpine binding sites in the rat brain: I. Pharmacological characterization

31 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

31 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Effects of DU 24565 (6-nitroquipazine) on serotoninergic and noradrenergic neurones of the rat brain and comparison with the effects of quipazine

31 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Aminergic systems in Alzheimer's disease and Parkinson's disease.

31 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

31 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Relationship between transmitter uptake inhibition and effects of alpha-adrenoceptor agonists on serotonin and noradrenaline release in the rat brain cortex.

31 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Characterization of [3H]paroxetine binding to rat cortical membranes.

31 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Binding of a specific 5-HT uptake inhibitor, [3H]norzimelidine, to rat brain homogenates.

31 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine

31 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Differentiation of two components of specific [3H]imipramine binding in rat brain

31 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

31 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Long-term biochemical and behavioral effects of p-chloroamphetamine in the rat.

31 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine.

31 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine

31 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Protein measurement with the Folin phenol reagent

31 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders.

31 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Characterization of [3H]paroxetine binding in rat brain

31 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes

31 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Regional distribution of [3H]imipramine binding in rat brain

31 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Decreased imipramine binding in the brains of patients with depressive illness.

31 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Specific tricyclic antidepressant binding sites in rat brain

31 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen.

31 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Demonstration of specific high affinity binding sites for [3H] imipramine in human brain

31 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

High- and Low-Affinity Binding of [3H]Imipramine in Mouse Cerebral Cortex

31 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues

31 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

In vivo labeling of serotonin uptake sites with [3H]paroxetine

31 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Tritiated imipramine binding sites are decreased in the frontal cortex of suicides.

31 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor

31 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90310-3

31 October 2022

Identifiers

1 reference

17 February 2018

1 reference

17 February 2018